Novel Pharmacological Approaches to the Treatment of Depression
Major depressive disorder is one of the most prevalent mental health disorders. Monoamine-based antidepressants were the first drugs developed to treat major depressive disorder. More recently, ketamine and other analogues were introduced as fast-acting antidepressants. Unfortunately, currently avai...
Main Authors: | Elias Elias, Ariel Y. Zhang, Melissa T. Manners |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | Life |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-1729/12/2/196 |
Similar Items
-
The dynamic interaction between symptoms and pharmacological treatment in patients with major depressive disorder: the role of network intervention analysis
by: Claudia Savia Guerrera, et al.
Published: (2023-11-01) -
Research progress of non-monoamine antidepressants
by: Huan Zhang, et al.
Published: (2021-12-01) -
Pharmacological Treatments for Patients with Treatment-Resistant Depression
by: Valerie L. Ruberto, et al.
Published: (2020-06-01) -
The monoamine theory of depression as a target to effective pharmacotherapy
by: Karabin Tomasz, et al.
Published: (2023-06-01) -
Emerging Medications for Treatment-Resistant Depression: A Review with Perspective on Mechanisms and Challenges
by: Michael J. Lucido, et al.
Published: (2025-02-01)